How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull ' s-eye In Obesity Treatment

Novo Nordisk said Friday its obesity treatment, Wegovy, reduced heart-failure symptoms. But Novo Nordisk stock remained flat. The post How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment appeared first on Investor's Business Daily.#novonordisk
Source: Reuters: Health - Category: Consumer Health News Source Type: news